- PD-1 inhibitors in the treatment of advanced esophageal cancer2021 | Publication without faculty affiliation
- Development of Resistant GvHD in a Patient Treated with Nivolumab for Hodgkins Lymphoma Relapse after Allogeneic Unrelated Transplantation2019 | Publication without faculty affiliation
- Immunotherapy of renal cell carcinoma2018 | First Faculty of Medicine
- Pembrolizumab - another successfull therapy in the treatment of melanoma2016 | Third Faculty of Medicine
- Advanced stages of classical Hodgkin lymphoma - first-line treatment options2021 | Third Faculty of Medicine
- Immuno-oncological treatment of melanoma2014 | Publication without faculty affiliation